You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Francis Hawkwood--Hogwood (1620/1630-1676/1677), of Scottish lineage, immigrated from England to Charles City County, Virginoa during or before 1650. He married Elizabeth Creed, and moved to Surry County, Virginia. Descendants and relatives lived in Virginia, North Caro- lina, South Carolina, Georgia, Alabama, Mississippi, Tennessee, Texas and elsewhere.
None
For many years, experiments using chimpanzees have been instrumental in advancing scientific knowledge and have led to new medicines to prevent life-threatening and debilitating diseases. However, recent advances in alternate research tools have rendered chimpanzees largely unnecessary as research subjects. The Institute of Medicine, in collaboration with the National Research Council, conducted an in-depth analysis of the scientific necessity for chimpanzees in NIH-funded biomedical and behavioral research. The committee concludes that while the chimpanzee has been a valuable animal model in the past, most current biomedical research use of chimpanzees is not necessary, though noted that it is impossible to predict whether research on emerging or new diseases may necessitate chimpanzees in the future.
Moses Barber (ca. 1652-1728) married twice and lived in South Kingston, Rhode Island. Descendants lived in New England, New York, Illinois, Nebraska, Kansas, Georgia, Florida and elsewhere.
The basic biology of the HIV virus provides a model for a more general understanding of retroviruses, and the worldwide epidemic of AIDS makes research into the disease process and potential therapies among the most critical in biomedical science. This book explores work on the molecular biology of HIV, host-virus interactions, host immune responses, HIV transmission, and more.
Cases argued and determined in the Supreme Court of North Carolina.
Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. Only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure.